Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review)

Author:

Luo Wenyu1,Guo Shiqi2,Zhou Yang2,Zhu Junfeng3,Zhao Jingwen4,Wang Mengyao4,Sang Lixuan4,Wang Bingyuan5,Chang Bing1

Affiliation:

1. Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110122, P.R. China

2. 104K class 87, The Second Clinical College, China Medical University, Shenyang, Liaoning 110122, P.R. China

3. Department of Clinical Laboratory, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China

4. Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China

5. Department of Geriatric Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110122, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference95 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer;Sung;J Clin,2021

2. A global view of hepatocellular carcinoma: Trends, risk, prevention and management;Yang;Nat Rev Gastroenterol Hepatol,2019

3. NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options;Foerster;J Hepatol,2022

4. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2021

5. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice;Liu;Hepatology,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3